Clinical Trial Update: Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients [Phase 2]

View source ↗

Summary

Phase IIb study of MP4OX in traumatic hemorrhagic shock patients has completed. The entry notes the trial status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lactic Acidosis
• Traumatic Hemorrhagic Shock

Drugs mentioned

• MP4OX

Snippet

Sponsor: Sangart | Conditions: Shock, Hemorrhagic, Shock, Traumatic | Phase 2 | Status: COMPLETED